WallStreetZenWallStreetZen

NASDAQ: ASTH
Astrana Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ASTH stock forecasts and price targets.

Forecast return on equity

Is ASTH forecast to generate an efficient return?

Company
24.9%
Industry
-97.25%
Market
-63.07%
ASTH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ASTH forecast to generate an efficient return on assets?

Company
13.94%
Industry
10.79%
ASTH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ASTH earnings per share forecast

What is ASTH's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$1.24+67.57%
Avg 2 year Forecast
$2.30+210.81%
Avg 3 year Forecast
$2.75+271.62%
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ASTH revenue forecast

What is ASTH's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$3.2B+42.37%
Avg 2 year Forecast
$4.0B+78.27%
Avg 3 year Forecast
$4.3B+92.97%
ASTH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ASTH earnings growth forecast

How is ASTH forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
58.1%
Industry
10.24%
Market
15.54%
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ASTH revenue growth forecast

How is ASTH forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
26.19%
Industry
4.35%
Market
11.62%
ASTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ASTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ASTH vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
ASTH$30.48N/AN/A
SEM$13.60$16.33+20.10%Buy
GRDN$24.41$30.00+22.90%Strong Buy
NHC$122.49N/AN/A
PACS$12.69N/AN/A
View Top Medical Care Facility Stocks

Astrana Health Stock Forecast FAQ

What is ASTH's earnings growth forecast for 2025-2027?

(NASDAQ: ASTH) Astrana Health's forecast annual earnings growth rate of 58.1% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 10.24%, and it is also forecast to beat the US market's average forecast earnings growth rate of 15.54%.

Astrana Health's earnings in 2025 is $35,006,000.On average, 2 Wall Street analysts forecast ASTH's earnings for 2025 to be $69,516,523, with the lowest ASTH earnings forecast at $66,713,437, and the highest ASTH earnings forecast at $72,319,608. On average, 2 Wall Street analysts forecast ASTH's earnings for 2026 to be $128,941,938, with the lowest ASTH earnings forecast at $123,335,766, and the highest ASTH earnings forecast at $134,548,109.

In 2027, ASTH is forecast to generate $154,169,708 in earnings, with the lowest earnings forecast at $154,169,708 and the highest earnings forecast at $154,169,708.

If you're new to stock investing, here's how to buy Astrana Health stock.

What is ASTH's revenue growth forecast for 2025-2027?

(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 26.19% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.35%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.62%.

Astrana Health's revenue in 2025 is $2,250,574,000.On average, 3 Wall Street analysts forecast ASTH's revenue for 2025 to be $179,625,425,321, with the lowest ASTH revenue forecast at $178,892,922,992, and the highest ASTH revenue forecast at $180,294,465,792. On average, 3 Wall Street analysts forecast ASTH's revenue for 2026 to be $224,928,894,788, with the lowest ASTH revenue forecast at $221,112,998,299, and the highest ASTH revenue forecast at $228,081,469,101.

In 2027, ASTH is forecast to generate $243,476,015,216 in revenue, with the lowest revenue forecast at $243,476,015,216 and the highest revenue forecast at $243,476,015,216.

What is ASTH's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: ASTH) forecast ROA is 13.94%, which is higher than the forecast US Medical Care Facilities industry average of 10.79%.

What is ASTH's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: ASTH) Astrana Health's current Earnings Per Share (EPS) is $0.74. On average, analysts forecast that ASTH's EPS will be $1.24 for 2025, with the lowest EPS forecast at $1.19, and the highest EPS forecast at $1.29. On average, analysts forecast that ASTH's EPS will be $2.30 for 2026, with the lowest EPS forecast at $2.20, and the highest EPS forecast at $2.40. In 2027, ASTH's EPS is forecast to hit $2.75 (min: $2.75, max: $2.75).

What is ASTH's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: ASTH) forecast ROE is 24.9%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.